$CLRI
Cleartronic, Inc.

2024 Q2 Form 10-Q Financial Statement

#000109181824000052 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.005M $572.0K
YoY Change 79.35% 12.01%
Cost Of Revenue $319.7K $108.0K
YoY Change 296.14% 50.99%
Gross Profit $685.3K $464.0K
YoY Change 42.88% 5.66%
Gross Profit Margin 68.19% 81.11%
Selling, General & Admin $602.4K $447.5K
YoY Change 28.61% 23.72%
% of Gross Profit 87.9% 96.44%
Research & Development $2.000K $3.044K
YoY Change 0.0% 52.2%
% of Gross Profit 0.29% 0.66%
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit 0.0% 0.0%
Operating Expenses $606.7K $452.0K
YoY Change 28.62% 23.85%
Operating Profit $78.60K $11.97K
YoY Change 890.69% -83.86%
Interest Expense $6.260K $9.360K
YoY Change 807.25% 1276.47%
% of Operating Profit 7.96% 78.19%
Other Income/Expense, Net $6.255K $9.356K
YoY Change 811.81% 1279.94%
Pretax Income $84.86K $21.33K
YoY Change 884.41% -71.5%
Income Tax
% Of Pretax Income
Net Earnings $84.86K $21.33K
YoY Change 884.41% -71.5%
Net Earnings / Revenue 8.44% 3.73%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 229.2M shares 229.2M shares
Diluted Shares Outstanding 599.5M shares 599.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $789.2K $673.6K
YoY Change 85.04% 74.62%
Cash & Equivalents $789.2K $673.6K
Short-Term Investments
Other Short-Term Assets $71.52K $95.69K
YoY Change -21.69% 184.62%
Inventory $129.9K $31.17K
Prepaid Expenses $71.52K $95.69K
Receivables $406.7K $611.5K
Other Receivables $4.860K $4.140K
Total Short-Term Assets $1.402M $1.416M
YoY Change 21.99% 45.42%
LONG-TERM ASSETS
Property, Plant & Equipment $39.86K $18.28K
YoY Change 122.87% 6.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $247.2K $262.9K
YoY Change 130.86% 134.17%
TOTAL ASSETS
Total Short-Term Assets $1.402M $1.416M
Total Long-Term Assets $247.2K $262.9K
Total Assets $1.649M $1.679M
YoY Change 31.27% 54.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $127.2K $38.43K
YoY Change 45.96% -51.84%
Accrued Expenses $12.89K $19.14K
YoY Change -46.09% -17.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.580M $1.583M
YoY Change 42.05% 68.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.10K $52.15K
YoY Change -57.92% -51.9%
Total Long-Term Liabilities $40.10K $52.15K
YoY Change -57.92% -51.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.580M $1.583M
Total Long-Term Liabilities $40.10K $52.15K
Total Liabilities $1.620M $1.635M
YoY Change 34.16% 56.37%
SHAREHOLDERS EQUITY
Retained Earnings -$15.21M -$15.20M
YoY Change 0.13% -0.02%
Common Stock $2.291K $2.291K
YoY Change 0.09% 0.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.61K $44.17K
YoY Change
Total Liabilities & Shareholders Equity $1.649M $1.679M
YoY Change 31.27% 54.6%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $84.86K $21.33K
YoY Change 884.41% -71.5%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Operating Activities $108.2K -$88.33K
YoY Change 152.3% -180.37%
INVESTING ACTIVITIES
Capital Expenditures -$7.430K $56.60K
YoY Change -450.47% 1210.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $7.430K -$56.60K
YoY Change -450.47% 1210.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 108.2K -88.33K
Cash From Investing Activities 7.430K -56.60K
Cash From Financing Activities 0.000
Net Change In Cash 115.6K -144.9K
YoY Change 183.66% -237.26%
FREE CASH FLOW
Cash From Operating Activities $108.2K -$88.33K
Capital Expenditures -$7.430K $56.60K
Free Cash Flow $115.6K -$144.9K
YoY Change 183.66% -237.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2024Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
clri Series C Convertible Preferred Shares Exchanged For Common Stock
SeriesCConvertiblePreferredSharesExchangedForCommonStock
usd
clri Rightofuse Asset Obtained In Exchange For New Operating Lease Liability
RightofuseAssetObtainedInExchangeForNewOperatingLeaseLiability
usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
usd
dei Security Exchange Name
SecurityExchangeName
NONE
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
229160695 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
516955 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
78665 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
63665 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
545573 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
31173 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
21913 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
95689 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
68522 usd
CY2024Q1 clri Interest Receivable Related Party Current
InterestReceivableRelatedPartyCurrent
4139 usd
CY2023Q3 clri Interest Receivable Related Party Current
InterestReceivableRelatedPartyCurrent
2724 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1416139 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1155687 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18276 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16526 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
173397 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44373 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17949 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29914 usd
CY2024Q1 clri Due From Related Party Non Current
DueFromRelatedPartyNonCurrent
53302 usd
CY2023Q3 clri Due From Related Party Non Current
DueFromRelatedPartyNonCurrent
53302 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
53302 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
53302 usd
CY2024Q1 us-gaap Assets
Assets
1679063 usd
CY2023Q3 us-gaap Assets
Assets
1299802 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
38428 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
85858 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1525176 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1105580 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19138 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24580 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1582742 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1216018 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
52150 usd
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
72100 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6507 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
52150 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
78607 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1634892 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1294625 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
229160695 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
229160695 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
229160695 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
229160695 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
2291 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2291 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240104 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240104 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15198298 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15237292 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
44171 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5177 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1679063 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1299802 usd
CY2024Q1 us-gaap Revenues
Revenues
572013 usd
CY2023Q1 us-gaap Revenues
Revenues
510668 usd
us-gaap Revenues
Revenues
1178060 usd
us-gaap Revenues
Revenues
1017318 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
108029 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
71546 usd
us-gaap Cost Of Revenue
CostOfRevenue
203660 usd
us-gaap Cost Of Revenue
CostOfRevenue
149037 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
463984 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
439122 usd
us-gaap Gross Profit
GrossProfit
974400 usd
us-gaap Gross Profit
GrossProfit
868281 usd
CY2024Q1 us-gaap Selling Expense
SellingExpense
87501 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
66831 usd
us-gaap Selling Expense
SellingExpense
207736 usd
us-gaap Selling Expense
SellingExpense
134662 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
359978 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
294858 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
765976 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
616756 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1490 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1282 usd
us-gaap Depreciation
Depreciation
2847 usd
us-gaap Depreciation
Depreciation
2362 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3044 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16603 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23815 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
452013 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
364971 usd
us-gaap Operating Expenses
OperatingExpenses
993162 usd
us-gaap Operating Expenses
OperatingExpenses
777595 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
44052 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9356 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
678 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13704 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1227 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9356 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
678 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
57756 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1227 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21327 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74829 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38994 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
91913 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
21327 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
74829 usd
us-gaap Profit Loss
ProfitLoss
38994 usd
us-gaap Profit Loss
ProfitLoss
91913 usd
CY2024Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10231 usd
CY2023Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10119 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
20574 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
20463 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11096 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64710 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18420 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
71450 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228780695 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228704541 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599406176 shares
us-gaap Net Income Loss
NetIncomeLoss
38994 usd
us-gaap Net Income Loss
NetIncomeLoss
91913 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2847 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2362 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
11965 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5983 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
15000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
80976 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7006 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9260 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
973 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
28582 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-18652 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-47430 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4585 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
399646 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-202147 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-11949 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5481 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
290255 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-78100 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4320 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
133621 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-133621 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4320 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
156634 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-82420 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
516955 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
673589 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
385747 usd
us-gaap Interest Paid Net
InterestPaidNet
117 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
400 usd
clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
7 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
47863 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5177 usd
us-gaap Profit Loss
ProfitLoss
38994 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
44171 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22844 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
21327 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
44171 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51379 usd
us-gaap Profit Loss
ProfitLoss
91913 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
40534 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-34295 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
74829 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
40534 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_z4IEqZ37MnW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zzNlbuStChKb">USE OF ESTIMATES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant estimates include the assumptions used in valuation of deferred tax assets, estimated useful life of property and equipment, valuation of inventory and allowance for credit losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
78665 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
63665 usd
CY2024Q1 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
12750 usd
CY2023Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
38250 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
95689 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
68522 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_z1sWTfSo3KU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_z5CkvYBFaT89">CONCENTRATION OF CREDIT RISK</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in non interest-bearing transaction accounts are insured up to a maximum of $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_c20240331_pp0p0" title="Fdic insured amount">250,000</span> at all FDIC-insured institutions. As of March 31, 2024 and September 30, 2023, the Company had $<span id="xdx_903_ecustom--AmountOfFdicInsuranceLimit_c20240331_pp0p0" title="Amount of fdic insurance limits">0</span> and $<span id="xdx_907_ecustom--AmountOfFdicInsuranceLimit_c20230930_pp0p0" title="Amount of fdic insurance limits">118,140</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q1 clri Amount Of Fdic Insurance Limit
AmountOfFdicInsuranceLimit
0 usd
CY2023Q3 clri Amount Of Fdic Insurance Limit
AmountOfFdicInsuranceLimit
118140 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3044 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16603 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23815 usd
CY2024Q1 us-gaap Deferred Revenue
DeferredRevenue
1577326 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
1177680 usd
CY2024Q1 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
572013 usd
CY2023Q1 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
510668 usd
us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
1178060 usd
us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
1017318 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10119 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
21327 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
74829 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228780695 shares
CY2024Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370321635 shares
CY2023Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370701635 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1177680 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1125511 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1178060 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2184124 usd
us-gaap Contract With Customer Asset Allowance For Credit Loss Writeoff
ContractWithCustomerAssetAllowanceForCreditLossWriteoff
778414 usd
CY2023 us-gaap Contract With Customer Asset Allowance For Credit Loss Writeoff
ContractWithCustomerAssetAllowanceForCreditLossWriteoff
2131955 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1577326 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1177680 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11096 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64710 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228780695 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18420 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
71450 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11096 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64710 usd
CY2024Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10231 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18420 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
71450 usd
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
20574 usd
us-gaap Profit Loss
ProfitLoss
38994 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228704541 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370701635 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599406176 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
31173 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
21913 usd
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
38108 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
17618 usd
us-gaap Advertising Expense
AdvertisingExpense
60692 usd
us-gaap Advertising Expense
AdvertisingExpense
30767 usd
CY2023Q1 us-gaap Area Of Land
AreaOfLand
1145 sqft
us-gaap Payments For Rent
PaymentsForRent
2134 usd
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
2198 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17949 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29914 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19138 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
31087 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
clri Amorization On Rightofuse Opeating Lease Asset
AmorizationOnRightofuseOpeatingLeaseAsset
11966 usd
CY2023 clri Amorization On Rightofuse Opeating Lease Asset
AmorizationOnRightofuseOpeatingLeaseAsset
17949 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1408 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
2429 usd
us-gaap Lease Cost
LeaseCost
13014 usd
CY2023 us-gaap Lease Cost
LeaseCost
20378 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
12996 usd
CY2023 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
19206 usd
CY2023 clri Rightofuse Asset Obtained In Exchange For New Operating Lease Liability
RightofuseAssetObtainedInExchangeForNewOperatingLeaseLiability
47863 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
13188 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6594 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
19782 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
644 usd
CY2024Q1 clri Present Value Of Operating Lease Liability
PresentValueOfOperatingLeaseLiability
19138 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19138 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32637 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28040 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14361 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11514 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18276 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16526 usd
us-gaap Depreciation
Depreciation
2847 usd
us-gaap Depreciation
Depreciation
2362 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
173397 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
44373 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
173397 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44373 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2024Q1 us-gaap Cumulative Dividends
CumulativeDividends
226756 usd
CY2023Q3 us-gaap Cumulative Dividends
CumulativeDividends
205658 usd
CY2024Q1 clri Rent Expense
RentExpense
0 usd
CY2023Q1 clri Rent Expense
RentExpense
0 usd
clri Rent Expense
RentExpense
0 usd
clri Rent Expense
RentExpense
2343 usd
CY2024Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9000 usd
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
21000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
18000 usd
CY2024Q1 clri Advanced Amounts
AdvancedAmounts
53302 usd
CY2023Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
1145 sqft
CY2023Q4 clri Monthly Rental Cost
MonthlyRentalCost
2134 usd
CY2023Q4 clri Monthly Rent
MonthlyRent
2198 usd
CY2021Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
2000 sqft
CY2021Q4 clri Monthly Rental Cost
MonthlyRentalCost
2200 usd
CY2021Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-11-30
us-gaap Royalty Expense
RoyaltyExpense
10010 usd
us-gaap Royalty Expense
RoyaltyExpense
5640 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
44052 usd

Files In Submission

Name View Source Status
clri-20240331_def.xml Edgar Link unprocessable
0001091818-24-000052-index-headers.html Edgar Link pending
0001091818-24-000052-index.html Edgar Link pending
0001091818-24-000052.txt Edgar Link pending
0001091818-24-000052-xbrl.zip Edgar Link pending
clri-20240331.xsd Edgar Link pending
clri31032310q.htm Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clri-20240331_cal.xml Edgar Link unprocessable
clri-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clri31032310q_htm.xml Edgar Link completed
clri-20240331_lab.xml Edgar Link unprocessable